Cargando…

Impact of kidney function and kidney volume on intracranial aneurysms in patients with autosomal dominant polycystic kidney disease

Presently, only personal or family history of intracranial aneurysm/subarachnoid hemorrhage (IA/SAH) has been established as a risk factor for IA in autosomal dominant polycystic kidney disease (ADPKD). This study aimed to verify the association between kidney function/volume and IAs in patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Kataoka, Hiroshi, Akagawa, Hiroyuki, Yoshida, Rie, Iwasa, Naomi, Ushio, Yusuke, Akihisa, Taro, Sato, Masayo, Manabe, Shun, Makabe, Shiho, Kawachi, Keiko, Hoshino, Junichi, Tsuchiya, Ken, Nitta, Kosaku, Mochizuki, Toshio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9613770/
https://www.ncbi.nlm.nih.gov/pubmed/36302803
http://dx.doi.org/10.1038/s41598-022-22884-9
_version_ 1784820046357331968
author Kataoka, Hiroshi
Akagawa, Hiroyuki
Yoshida, Rie
Iwasa, Naomi
Ushio, Yusuke
Akihisa, Taro
Sato, Masayo
Manabe, Shun
Makabe, Shiho
Kawachi, Keiko
Hoshino, Junichi
Tsuchiya, Ken
Nitta, Kosaku
Mochizuki, Toshio
author_facet Kataoka, Hiroshi
Akagawa, Hiroyuki
Yoshida, Rie
Iwasa, Naomi
Ushio, Yusuke
Akihisa, Taro
Sato, Masayo
Manabe, Shun
Makabe, Shiho
Kawachi, Keiko
Hoshino, Junichi
Tsuchiya, Ken
Nitta, Kosaku
Mochizuki, Toshio
author_sort Kataoka, Hiroshi
collection PubMed
description Presently, only personal or family history of intracranial aneurysm/subarachnoid hemorrhage (IA/SAH) has been established as a risk factor for IA in autosomal dominant polycystic kidney disease (ADPKD). This study aimed to verify the association between kidney function/volume and IAs in patients with ADPKD. This study included 519 patients with ADPKD. At baseline IA screening, the median age and estimated glomerular filtration rate were 44 years and 54.5 mL/min/1.73 m(2), respectively. Family IA/SAH history was confirmed in 18.1% of the patients, and 54.3% of the patients had hypertension. The IA point prevalence was 12.5%. During clinical follow up of 3104 patient-years, de novo IA was detected in 29 patients (0.93% patient-years). The IA period prevalence was 18.1% (median age, 60 years). Multivariable logistic regression demonstrated that total kidney volume (TKV) ≥ 1000 mL (odds ratio [OR] = 2.81), height-adjusted TKV ≥ 500 mL (OR = 2.81), Mayo imaging classification Class 1D–1E (OR = 2.52), and chronic kidney disease stages 3–5 (OR = 2.31) were significantly associated with IA formation. IAs in patients with ADPKD may be associated not only with general risk factors for IAs but also with declining kidney function and increased KV. Kidney disease progression may contribute to effective IA screening and treatment planning in patients with ADPKD.
format Online
Article
Text
id pubmed-9613770
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-96137702022-10-29 Impact of kidney function and kidney volume on intracranial aneurysms in patients with autosomal dominant polycystic kidney disease Kataoka, Hiroshi Akagawa, Hiroyuki Yoshida, Rie Iwasa, Naomi Ushio, Yusuke Akihisa, Taro Sato, Masayo Manabe, Shun Makabe, Shiho Kawachi, Keiko Hoshino, Junichi Tsuchiya, Ken Nitta, Kosaku Mochizuki, Toshio Sci Rep Article Presently, only personal or family history of intracranial aneurysm/subarachnoid hemorrhage (IA/SAH) has been established as a risk factor for IA in autosomal dominant polycystic kidney disease (ADPKD). This study aimed to verify the association between kidney function/volume and IAs in patients with ADPKD. This study included 519 patients with ADPKD. At baseline IA screening, the median age and estimated glomerular filtration rate were 44 years and 54.5 mL/min/1.73 m(2), respectively. Family IA/SAH history was confirmed in 18.1% of the patients, and 54.3% of the patients had hypertension. The IA point prevalence was 12.5%. During clinical follow up of 3104 patient-years, de novo IA was detected in 29 patients (0.93% patient-years). The IA period prevalence was 18.1% (median age, 60 years). Multivariable logistic regression demonstrated that total kidney volume (TKV) ≥ 1000 mL (odds ratio [OR] = 2.81), height-adjusted TKV ≥ 500 mL (OR = 2.81), Mayo imaging classification Class 1D–1E (OR = 2.52), and chronic kidney disease stages 3–5 (OR = 2.31) were significantly associated with IA formation. IAs in patients with ADPKD may be associated not only with general risk factors for IAs but also with declining kidney function and increased KV. Kidney disease progression may contribute to effective IA screening and treatment planning in patients with ADPKD. Nature Publishing Group UK 2022-10-27 /pmc/articles/PMC9613770/ /pubmed/36302803 http://dx.doi.org/10.1038/s41598-022-22884-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Kataoka, Hiroshi
Akagawa, Hiroyuki
Yoshida, Rie
Iwasa, Naomi
Ushio, Yusuke
Akihisa, Taro
Sato, Masayo
Manabe, Shun
Makabe, Shiho
Kawachi, Keiko
Hoshino, Junichi
Tsuchiya, Ken
Nitta, Kosaku
Mochizuki, Toshio
Impact of kidney function and kidney volume on intracranial aneurysms in patients with autosomal dominant polycystic kidney disease
title Impact of kidney function and kidney volume on intracranial aneurysms in patients with autosomal dominant polycystic kidney disease
title_full Impact of kidney function and kidney volume on intracranial aneurysms in patients with autosomal dominant polycystic kidney disease
title_fullStr Impact of kidney function and kidney volume on intracranial aneurysms in patients with autosomal dominant polycystic kidney disease
title_full_unstemmed Impact of kidney function and kidney volume on intracranial aneurysms in patients with autosomal dominant polycystic kidney disease
title_short Impact of kidney function and kidney volume on intracranial aneurysms in patients with autosomal dominant polycystic kidney disease
title_sort impact of kidney function and kidney volume on intracranial aneurysms in patients with autosomal dominant polycystic kidney disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9613770/
https://www.ncbi.nlm.nih.gov/pubmed/36302803
http://dx.doi.org/10.1038/s41598-022-22884-9
work_keys_str_mv AT kataokahiroshi impactofkidneyfunctionandkidneyvolumeonintracranialaneurysmsinpatientswithautosomaldominantpolycystickidneydisease
AT akagawahiroyuki impactofkidneyfunctionandkidneyvolumeonintracranialaneurysmsinpatientswithautosomaldominantpolycystickidneydisease
AT yoshidarie impactofkidneyfunctionandkidneyvolumeonintracranialaneurysmsinpatientswithautosomaldominantpolycystickidneydisease
AT iwasanaomi impactofkidneyfunctionandkidneyvolumeonintracranialaneurysmsinpatientswithautosomaldominantpolycystickidneydisease
AT ushioyusuke impactofkidneyfunctionandkidneyvolumeonintracranialaneurysmsinpatientswithautosomaldominantpolycystickidneydisease
AT akihisataro impactofkidneyfunctionandkidneyvolumeonintracranialaneurysmsinpatientswithautosomaldominantpolycystickidneydisease
AT satomasayo impactofkidneyfunctionandkidneyvolumeonintracranialaneurysmsinpatientswithautosomaldominantpolycystickidneydisease
AT manabeshun impactofkidneyfunctionandkidneyvolumeonintracranialaneurysmsinpatientswithautosomaldominantpolycystickidneydisease
AT makabeshiho impactofkidneyfunctionandkidneyvolumeonintracranialaneurysmsinpatientswithautosomaldominantpolycystickidneydisease
AT kawachikeiko impactofkidneyfunctionandkidneyvolumeonintracranialaneurysmsinpatientswithautosomaldominantpolycystickidneydisease
AT hoshinojunichi impactofkidneyfunctionandkidneyvolumeonintracranialaneurysmsinpatientswithautosomaldominantpolycystickidneydisease
AT tsuchiyaken impactofkidneyfunctionandkidneyvolumeonintracranialaneurysmsinpatientswithautosomaldominantpolycystickidneydisease
AT nittakosaku impactofkidneyfunctionandkidneyvolumeonintracranialaneurysmsinpatientswithautosomaldominantpolycystickidneydisease
AT mochizukitoshio impactofkidneyfunctionandkidneyvolumeonintracranialaneurysmsinpatientswithautosomaldominantpolycystickidneydisease